These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 7254231

  • 1. Cross-reactivity of anti-acetylcholine receptor autoantibodies.
    Garlepp MJ, Kay PH, Dawkins RL, Bucknall RC, Kemp A.
    Muscle Nerve; 1981; 4(4):282-8. PubMed ID: 7254231
    [Abstract] [Full Text] [Related]

  • 2. Acetylcholine receptor antibody characteristics in myasthenia gravis. II. Patients with penicillamine-induced myasthenia or idiopathic myasthenia of recent onset.
    Vincent A, Newsom-Davis J.
    Clin Exp Immunol; 1982 Aug; 49(2):266-72. PubMed ID: 7127905
    [Abstract] [Full Text] [Related]

  • 3. Sequence analysis of anti-AChR antibodies in experimental autoimmune myasthenia gravis.
    Graus Y, Meng F, Vincent A, van Breda Vriesman P, de Baets M.
    J Immunol; 1995 Jun 15; 154(12):6382-96. PubMed ID: 7539019
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Characterization of human anti-acetylcholine receptor monoclonal autoantibodies from the peripheral blood of a myasthenia gravis patient using combinatorial libraries.
    Rey E, Zeidel M, Rhine C, Tami J, Krolick K, Fischbach M, Sanz I.
    Clin Immunol; 2000 Sep 15; 96(3):269-79. PubMed ID: 10964546
    [Abstract] [Full Text] [Related]

  • 10. On the initial trigger of myasthenia gravis and suppression of the disease by antibodies against the MHC peptide region involved in the presentation of a pathogenic T-cell epitope.
    Atassi MZ, Oshima M, Deitiker P.
    Crit Rev Immunol; 2001 Sep 15; 21(1-3):1-27. PubMed ID: 11642597
    [Abstract] [Full Text] [Related]

  • 11. Anti-MuSK- and anti-AChR-positive myasthenia gravis induced by d-penicillamine.
    Poulas K, Koutsouraki E, Kordas G, Kokla A, Tzartos SJ.
    J Neuroimmunol; 2012 Sep 15; 250(1-2):94-8. PubMed ID: 22683336
    [Abstract] [Full Text] [Related]

  • 12. The in vitro effects of D-penicillamine upon anti-AChR production by thymic and peripheral blood lymphocytes from patients with myasthenia gravis.
    Scadding GK, Calder L, Newsom-Davis J.
    Muscle Nerve; 1983 Sep 15; 6(9):656-60. PubMed ID: 6606776
    [Abstract] [Full Text] [Related]

  • 13. [Acetylcholine receptor antibody in D-penicillamine therapy].
    Kolarz G, Maida EM.
    Z Rheumatol; 1986 Sep 15; 45(3):118-21. PubMed ID: 3751350
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction.
    Cole RN, Reddel SW, Gervásio OL, Phillips WD.
    Ann Neurol; 2008 Jun 15; 63(6):782-9. PubMed ID: 18384168
    [Abstract] [Full Text] [Related]

  • 20. Effector mechanisms in myasthenia gravis: end-plate function after passive transfer of IgG, Fab, and F(ab')2 hybrid molecules.
    Sterz R, Hohlfeld R, Rajki K, Kaul M, Heininger K, Peper K, Toyka KV.
    Muscle Nerve; 1986 May 15; 9(4):306-12. PubMed ID: 2423869
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.